JenniferWeissMD(She/Her)

Pediatric Rheumatology • Hackensack, NJ

Associate Professor, Pediatrics, Hackensack Meridian Health School of Medicine

Join to view full profile

Dr. Weiss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weiss' full profile

Already have an account?

Office
30 Prospect Ave
# Hackensa
Hackensack, NJ 07601
Phone+1 201-996-5306

Fax+1 201-996-9815

Education & Training

Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Pediatric Rheumatology, 2001 - 2004
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1998 - 2001
St. George's University School of MedicineClass of 1998

Certifications & Licensure

NJ State Medical License 2004 - 2025
CT State Medical License 2005 - 2005
American Board of Pediatrics Pediatric Rheumatology

Awards, Honors, & Recognition

Fellow (FACR) American College of Rheumatology

Clinical Trials

Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Start of enrollment: 2003 Sep 01
Completed
Phase 3
Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults Start of enrollment: 2008 Nov 01
Completed
Phase 2
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA) Start of enrollment: 2008 May 01
Completed
Phase 3
A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis Start of enrollment: 2009 Nov 30
Completed
Phase 3
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis Start of enrollment: 2013 Mar 18
Active, not recruiting
Phase 2, Phase 3
Pediatric Arthritis Study of Certolizumab Pegol Start of enrollment: 2012 Mar 08
Completed
Phase 3
A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study Start of enrollment: 2012 Jan 01
Completed
Phase 3
An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study Start of enrollment: 2013 Mar 01
Completed
Phase 3
Biomarkers in Idiopathic Juvenile Arthritis Start of enrollment: 2015 Jun 01
Unknown status
Not Applicable
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry Start of enrollment: 2015 Jul 01
Recruiting
Efficacy Study Of Tofacitinib In Pediatric JIA Population Start of enrollment: 2016 Jun 10
Completed
Phase 3
Start Time Optimization of Biologics in Polyarticular JIA Start of enrollment: 2015 Nov 01
Completed
Join now to see all

Publications & Presentations

PubMed

49 citations
Age and fecal microbial strain-specific differences in patients with spondyloarthritis
Matthew L. Stoll, Pamela F. Weiss, Jennifer E. Weiss, Peter A. Nigrovic, Barbara Edelheit
Arthritis Research & Therapy. 2018-01-30
99 citations
Infliximab as a novel therapy for refractory Kawasaki disease.
Jennifer E Weiss, B Anne Eberhard, Devyani Chowdhury, Beth Gottlieb
The Journal of Rheumatology. 2004-04-01
23 citations
Pediatric Pain Syndromes and Noninflammatory Musculoskeletal Pain.
Jennifer E. Weiss, Jennifer Stinson
Pediatric Clinics of North America. 2018-08-01